|
1
|
Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection.
|
Ann Surg
|
2004
|
5.09
|
|
2
|
Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients.
|
Arch Surg
|
2003
|
4.86
|
|
3
|
Pancreatic ductal adenocarcinoma: long-term survival does not equal cure.
|
Surgery
|
2012
|
3.87
|
|
4
|
In vivo lineage tracing defines the role of acinar-to-ductal transdifferentiation in inflammatory ductal metaplasia.
|
Gastroenterology
|
2007
|
3.41
|
|
5
|
Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma.
|
J Clin Oncol
|
2006
|
3.37
|
|
6
|
Isolation and characterization of centroacinar/terminal ductal progenitor cells in adult mouse pancreas.
|
Proc Natl Acad Sci U S A
|
2009
|
3.25
|
|
7
|
A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway.
|
Cancer Res
|
2006
|
3.06
|
|
8
|
Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection.
|
Gastroenterology
|
2007
|
2.96
|
|
9
|
Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients.
|
Ann Surg
|
2008
|
2.45
|
|
10
|
Implications and cost of pancreatic leak following distal pancreatic resection.
|
Arch Surg
|
2006
|
2.25
|
|
11
|
Incidental pancreatic cysts: do we really know what we are watching?
|
Pancreatology
|
2010
|
2.22
|
|
12
|
PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network.
|
Cancer Discov
|
2011
|
2.14
|
|
13
|
Plectin-1 as a novel biomarker for pancreatic cancer.
|
Clin Cancer Res
|
2010
|
2.03
|
|
14
|
Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines.
|
J Natl Compr Canc Netw
|
2012
|
1.97
|
|
15
|
Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes.
|
Gut
|
2011
|
1.94
|
|
16
|
Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics.
|
Clin Gastroenterol Hepatol
|
2009
|
1.90
|
|
17
|
Pancreatic duct glands are distinct ductal compartments that react to chronic injury and mediate Shh-induced metaplasia.
|
Gastroenterology
|
2009
|
1.78
|
|
18
|
Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes.
|
Arch Surg
|
2011
|
1.78
|
|
19
|
FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience.
|
Oncologist
|
2013
|
1.76
|
|
20
|
Epidermal growth factor receptor kinase domain mutations in esophageal and pancreatic adenocarcinomas.
|
Clin Cancer Res
|
2006
|
1.75
|
|
21
|
Implications and management of pancreatic fistulas following pancreaticoduodenectomy: the Massachusetts General Hospital experience.
|
Arch Surg
|
2008
|
1.72
|
|
22
|
Debridement and closed packing for sterile or infected necrotizing pancreatitis: insights into indications and outcomes in 167 patients.
|
Ann Surg
|
2008
|
1.69
|
|
23
|
851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital.
|
Surgery
|
2012
|
1.68
|
|
24
|
Current trends in pancreatic cystic neoplasms.
|
Arch Surg
|
2009
|
1.68
|
|
25
|
Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series.
|
Ann Surg
|
2013
|
1.58
|
|
26
|
Pancreatic adenocarcinoma.
|
J Natl Compr Canc Netw
|
2010
|
1.52
|
|
27
|
Middle pancreatectomy: indications, short- and long-term operative outcomes.
|
Ann Surg
|
2007
|
1.46
|
|
28
|
Metastatic tumors in the pancreas in the modern era.
|
J Am Coll Surg
|
2010
|
1.45
|
|
29
|
Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005.
|
Arch Surg
|
2007
|
1.45
|
|
30
|
Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts General Hospital.
|
Ann Surg
|
2008
|
1.45
|
|
31
|
Evolution of the Whipple procedure at the Massachusetts General Hospital.
|
Surgery
|
2012
|
1.40
|
|
32
|
Beta cell transdifferentiation does not contribute to preneoplastic/metaplastic ductal lesions of the pancreas by genetic lineage tracing in vivo.
|
Proc Natl Acad Sci U S A
|
2007
|
1.39
|
|
33
|
Pancreatic fistula rates after 462 distal pancreatectomies: staplers do not decrease fistula rates.
|
J Gastrointest Surg
|
2008
|
1.38
|
|
34
|
Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival.
|
J Clin Oncol
|
2005
|
1.37
|
|
35
|
Global genomic analysis of intraductal papillary mucinous neoplasms of the pancreas reveals significant molecular differences compared to ductal adenocarcinoma.
|
Ann Surg
|
2009
|
1.17
|
|
36
|
Epithelial cell guidance by self-generated EGF gradients.
|
Integr Biol (Camb)
|
2012
|
1.17
|
|
37
|
Distal pancreatectomy with splenic preservation revisited.
|
Surgery
|
2007
|
1.14
|
|
38
|
Surgery for small and asymptomatic branch-duct IPMNs.
|
Ann Surg
|
2014
|
1.13
|
|
39
|
Early detection of sporadic pancreatic cancer: summative review.
|
Pancreas
|
2015
|
1.10
|
|
40
|
N0/N1, PNL, or LNR? The effect of lymph node number on accurate survival prediction in pancreatic ductal adenocarcinoma.
|
J Gastrointest Surg
|
2012
|
1.09
|
|
41
|
Quality of life in pancreatic cancer: analysis by stage and treatment.
|
J Gastrointest Surg
|
2008
|
1.07
|
|
42
|
Added value of selected images embedded into radiology reports to referring clinicians.
|
J Am Coll Radiol
|
2010
|
1.05
|
|
43
|
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?: a 10-year contemporary experience with 1,173 patients at the Massachusetts General Hospital.
|
J Gastrointest Surg
|
2013
|
1.03
|
|
44
|
Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010.
|
Cancer
|
2013
|
0.99
|
|
45
|
Plectin-1 is a biomarker of malignant pancreatic intraductal papillary mucinous neoplasms.
|
J Gastrointest Surg
|
2009
|
0.98
|
|
46
|
Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio.
|
Ann Surg
|
2010
|
0.98
|
|
47
|
Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma.
|
Angiogenesis
|
2011
|
0.96
|
|
48
|
Circulating tumor cells found in patients with localized and advanced pancreatic cancer.
|
Pancreas
|
2015
|
0.94
|
|
49
|
Preoperative platelet count and survival prognosis in resected pancreatic ductal adenocarcinoma.
|
World J Surg
|
2008
|
0.92
|
|
50
|
High performing whipple patients: factors associated with short length of stay after open pancreaticoduodenectomy.
|
J Gastrointest Surg
|
2014
|
0.92
|
|
51
|
Management of mucin-producing cystic neoplasms of the pancreas.
|
Oncologist
|
2009
|
0.89
|
|
52
|
Decreased inflammation and improved survival with recombinant human activated protein C treatment in experimental acute pancreatitis.
|
Arch Surg
|
2006
|
0.88
|
|
53
|
Pancreaticoduodenectomy.
|
J Gastrointest Surg
|
2004
|
0.87
|
|
54
|
Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma?
|
J Gastrointest Surg
|
2009
|
0.87
|
|
55
|
Imaging of acute mesenteric ischemia using multidetector CT and CT angiography in a porcine model.
|
J Gastrointest Surg
|
2005
|
0.85
|
|
56
|
Sonic Hedgehog in pancreatic cancer: from bench to bedside, then back to the bench.
|
Surgery
|
2012
|
0.83
|
|
57
|
Magnetic resonance imaging monitors physiological changes with antihedgehog therapy in pancreatic adenocarcinoma xenograft model.
|
Pancreas
|
2008
|
0.83
|
|
58
|
Management of the Primary Tumor and Limited Metastases in Patients With Metastatic Pancreatic Cancer.
|
J Natl Compr Canc Netw
|
2015
|
0.82
|
|
59
|
Intraductal papillary mucinous neoplasms: does a family history of pancreatic cancer matter?
|
Pancreatology
|
2012
|
0.80
|
|
60
|
Targeting the MAGE A3 antigen in pancreatic cancer.
|
Surgery
|
2012
|
0.78
|
|
61
|
Novel xenograft and cell line derived from an invasive intraductal papillary mucinous neoplasm of the pancreas give new insights into molecular mechanisms.
|
Pancreas
|
2010
|
0.78
|
|
62
|
Identification of a novel kindred with familial pancreatitis and pancreatic cancer.
|
Pancreatology
|
2009
|
0.77
|